Delivery Order SPE2DB20D2014-SPE2DB25FC80X
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $23,123.28 on August 7, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AVEED 750 MG/3 ML vials. This competitive, firm fixed-price delivery order, valued at $2,890.41, was executed on August 22, 2025, with an ultimate completion date of September 15, 2025. The products will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The U.S. Defense Logistics Agency (DLA) awarded a $27,954.72 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,717,571 units of AVEED 750 MG/3 ML VIAL 3ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
- The Defense Logistics Agency Troop Support Medical awarded a $17,766 firm fixed price delivery order to Amerisourcebergen Drug Corporation for AVEED 750 MG/3 ML vials. The order is for 3ML vials of AVEED, a medication used to treat conditions such as hormone deficiency. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September 26 and October 18, 2023. The Defense Logistics Agency manages the Department of Defense's...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,300.50 firm fixed-price delivery order is for the supply of AVEED 750 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of August 16, 2022 and was awarded on July 26, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,926.94 firm fixed-price delivery order is for the medical product "AVEED 750 MG/3 ML VIAL 3ML" and has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of AVEED 750 MG/3 ML VIAL 3ML medical products. The $28,095.12 firm-fixed-price delivery order has an ultimate completion date of March 7, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC80XDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 21, 2025, with completion targeted for September 12, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a long-acting testosterone replacement therapy indicated for treating hypogonadism in men, representing the type of specialized pharmaceutical product within AmerisourceBergen's federal medical supply portfolio. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime contract vehicle designated SPE2DX and extending through December 2026. The parent IDC provides comprehensive global pharmaceutical support across multiple therapeutic domains for military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. AmerisourceBergen's successful track record of competitively awarded contracts with DLA demonstrates its capability to fulfill federal medical procurement requirements, and the company serves as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.5k | 8/21/25 |